Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ploeger

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pharmacology|December 8, 2016
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis SymptomsIsabel Reinecke, Marcus-Hillert Schultze-Mosgau, Rüdiger Nave, et al.
Bulletin of Mathematical Biology|October 7, 2006
Application of the convection-dispersion equation to modelling oral drug absorptionJan I Freijer, Teun M Post, Bart A Ploeger, et al.
Clinical Pharmacokinetics|September 27, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive OverviewMarcus-Hillert Schultze-Mosgau, Bart A Ploeger, Matthias Frei, et al.
Acta Biomaterialia|February 5, 2013
Macrophage phenotypes in the collagen-induced foreign body reaction in ratsSander M van Putten, Diana T A Ploeger, Eliane R Popa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limitD Garmann, S McLeay, A Shah, et al.
British Journal of Clinical Pharmacology|May 3, 2020
Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intakeAnne Keunecke, Sven Hoefman, Henk-Jan Drenth, et al.
Tissue Engineering. Part C, Methods|January 19, 2016
3,4-Dihydroxy-L-Phenylalanine as a Novel Covalent Linker of Extracellular Matrix Proteins to Polyacrylamide Hydrogels with a Tunable StiffnessOlaf Y Wouters, Diana T A Ploeger, Sander M van Putten, et al.
Journal of Clinical Pharmacology|February 28, 2013
Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazarFrances Stringer, Bart A Ploeger, Joost DeJongh, et al.
Clinical Nephrology|March 1, 1997
Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection?M K Dousa, S B Moore, N A Ploeger, et al.
Journal of Health Communication|October 4, 2012
Communication competence, social support, and depression among college students: a model of facebook and face-to-face support network influenceKevin B Wright, Jenny Rosenberg, Nicole Egbert, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pharmacology|December 8, 2016
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis SymptomsIsabel Reinecke, Marcus-Hillert Schultze-Mosgau, Rüdiger Nave, et al.
Bulletin of Mathematical Biology|October 7, 2006
Application of the convection-dispersion equation to modelling oral drug absorptionJan I Freijer, Teun M Post, Bart A Ploeger, et al.
Clinical Pharmacokinetics|September 27, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive OverviewMarcus-Hillert Schultze-Mosgau, Bart A Ploeger, Matthias Frei, et al.
Acta Biomaterialia|February 5, 2013
Macrophage phenotypes in the collagen-induced foreign body reaction in ratsSander M van Putten, Diana T A Ploeger, Eliane R Popa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limitD Garmann, S McLeay, A Shah, et al.
British Journal of Clinical Pharmacology|May 3, 2020
Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intakeAnne Keunecke, Sven Hoefman, Henk-Jan Drenth, et al.
Tissue Engineering. Part C, Methods|January 19, 2016
3,4-Dihydroxy-L-Phenylalanine as a Novel Covalent Linker of Extracellular Matrix Proteins to Polyacrylamide Hydrogels with a Tunable StiffnessOlaf Y Wouters, Diana T A Ploeger, Sander M van Putten, et al.
Journal of Clinical Pharmacology|February 28, 2013
Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazarFrances Stringer, Bart A Ploeger, Joost DeJongh, et al.
Clinical Nephrology|March 1, 1997
Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection?M K Dousa, S B Moore, N A Ploeger, et al.
Journal of Health Communication|October 4, 2012
Communication competence, social support, and depression among college students: a model of facebook and face-to-face support network influenceKevin B Wright, Jenny Rosenberg, Nicole Egbert, et al.
Pageof 7